Spark Health

Spark Health Spark Health is a social-first digital marketing agency built for the modern healthcare landscape.

From Autumn 2026, community pharmacists in England will be able to independently assess patients and prescribe medicines...
17/06/2026

From Autumn 2026, community pharmacists in England will be able to independently assess patients and prescribe medicines directly under a new £340 million NHS deal.

Most pharma HCP engagement strategies are still built around GPs, hospital specialists and MSL touchpoints.

The prescriber audience is broadening, and it is broadening quickly. Between March 2025 and February 2026, Pharmacy prescribers delivered over 3.3 million consultations, up 43% year on year.

If your digital engagement strategy has not been updated to reflect the shift, now is the time. Speak to us to find out how [email protected]



Source: https://www.gov.uk/government/news/340m-pharmacy-boost-brings-faster-care-to-your-high-street

A 2025 survey by IQVIA of more than 33,000 HCPs across 38 countries found that in the UK only 43% of HCP interactions ma...
10/06/2026

A 2025 survey by IQVIA of more than 33,000 HCPs across 38 countries found that in the UK only 43% of HCP interactions match the channels HCPs say they prefer.

At the same time, HCP use of social media for clinical content is rising.

Addressing the gap means understanding where HCPs actually spend their time and which channels they prefer to use, then building your marketing strategy around those preferences - rather than convenience.

For many pharma teams, LinkedIn represents a significant untapped opportunity: verified professional targeting, a growing healthcare audience, and a content environment where educational, disease-focused material consistently outperforms corporate broadcasting.

We help pharma marketing and medical affairs teams build LinkedIn strategies that close this gap. Get in touch if you’d like to know more 👉 [email protected]

Sources: EPG Health, IQVIA

Most pharma campaigns are built around acquisition. Getting the right person to the right place at the right moment. Wha...
26/05/2026

Most pharma campaigns are built around acquisition. Getting the right person to the right place at the right moment. What happens after that first interaction is where most of the value is lost.

A cardiologist visits your therapy area page during a lunch break. Reads half an article. Gets called away.

A specialist nurse watches your mechanism of action video, then closes the tab.

A patient newly diagnosed with a chronic condition finds your disease awareness page, spends three minutes reading, and does not come back.

None of these are failures. They are warm audiences with demonstrated interest. Remarketing is how you follow up to help realise the value. Here are three ways pharma teams are putting remarketing to work.

Read our full guide to remarketing in pharma bit.ly/42UNcRu

How can pharma brands build trust in a social landscape they do not control? This issue kept surfacing at this week's Ph...
15/05/2026

How can pharma brands build trust in a social landscape they do not control? This issue kept surfacing at this week's Pharma Social Media Conference 2026 in London.

There isn’t one single answer. But there is a clear direction of travel. Speakers from across the industry brought sharp perspectives to themes that dominated the day.

Swipe to see our key takeaways.

The PMCPA updated its social media guidance earlier this year and for pharma marketers in the UK, it is worth reading ca...
28/04/2026

The PMCPA updated its social media guidance earlier this year and for pharma marketers in the UK, it is worth reading carefully.

The direction is positive. Acknowledging the realities of modern digital marketing in pharma and providing clearer parameters for remaining compliant on social.

Here are our three key takeaways for pharma marketers in the UK.

Online engagement.
Liking or reposting third-party content can constitute "active dissemination" under the ABPI Code. Clear, documented internal protocols are essential.

Influencer partnerships.
Companies remain fully responsible for third-party content published on their behalf. Generic tags like " " may no longer be sufficient. Your contracts and approval processes need to reflect this.

Audience signposting.
Clearer audience gating is expected to keep HCP-only content appropriately separated from public-facing material. Pharma marketers with well-governed digital programmes will find this update largely validates their approach. Those without should treat it as a prompt to act.

Read the official update here: https://www.pmcpa.org.uk/guidance-and-qas/pmcpa-social-media-guidance/

In pharmaceutical marketing, digital compliance is non-negotiable but it shouldn't be a barrier to creativity.You don’t ...
21/04/2026

In pharmaceutical marketing, digital compliance is non-negotiable but it shouldn't be a barrier to creativity.

You don’t have to compromise on highly engaging and creative campaigns for adherence to ABPI, FDA, EMA, or local regulatory requirements.

You can do both.

Backed by our network of local regulatory and pharmacovigilance experts we can help you deliver a next-gen patient & HCP digital experience whilst remaining compliant.

For more insight into what’s possible - speak to our team.

The HCP journey with your brand doesn't follow a linear path. It spans dozens of touchpoints from journal ads and Google...
17/04/2026

The HCP journey with your brand doesn't follow a linear path.

It spans dozens of touchpoints from journal ads and Google searches to MSL discussions, virtual meetings, and LinkedIn webinars.

But what does ‘poor digital delivery’ actually look like?

Here are some of the most common issues in our experience.

⚫ Generic, one-size-fits-all messaging that is not optimised for the format, channel or stage in the journey.

⚫ Communication that prioritises volume over relevance.

⚫ Content that fails to advance clinical discussions or education.

⚫ Lack of audience segmentation, resulting in HCP and patient communications that feel interchangeable.

⚫ Slow, poorly designed digital platforms that create unnecessary friction for users seeking critical information.

⚫ Infrequent or inconsistent publishing across social media that fails to build meaningful presence or community over time.

⚫ An absence of data and performance measurement, meaning campaigns are repeated without learning or iteration.

⚫ Failure to adapt content formats for the specific platforms and environments where audiences are active.

As a life science brand, your customers are online, engaged, and receptive to the right content.

The challenge isn't access, it's ex*****on.

If you need help avoiding ‘poor digital delivery’ - our specialist team can help. Contact us at [email protected].

Spark Health will be at the 10th annual Pharma Social Media Conference in London on 12th May - and this year's agenda is...
13/04/2026

Spark Health will be at the 10th annual Pharma Social Media Conference in London on 12th May - and this year's agenda is one of the strongest yet.

The day brings together senior digital and social leaders from Novartis, Pfizer UK, Sanofi, Roche, GSK, Chiesi Group, Novo Nordisk, Merck, and the ABPI to tackle the topics that matter most to pharma social media teams right now:

🔳 AI in social - practical use cases, ethical adoption, and separating value from hype.
🔳 Creative and compliant content - how to push boundaries without compromising regulatory credibility.
🔳 HCP engagement - which platforms, formats, and content types are driving real participation.
🔳 Patient engagement - building trust and community through authentic social storytelling.
🔳 TikTok in pharma - a candid discussion on the strategic opportunity and the risks.
🔳 Measuring ROI - frameworks that connect social activity to meaningful commercial outcomes.
🔳 Navigating social regulations - including the latest on PMCPA UK guidelines and evolving digital compliance

If you are attending and would like to meet with the Spark Health team on the day, get in touch at [email protected]

📍 Copthorne Tara Hotel, Kensington, London 📅 12th May 2026

Address

London Borough Of Islington

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm

Telephone

02074594495

Website

Alerts

Be the first to know and let us send you an email when Spark Health posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Spark Health:

Shortcuts

Share

Category